RJA
MDRX

Raymond James & Associates’s Veradigm Inc. Common Stock MDRX Stock Holding History

Raymond James & Associates’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,505
Closed -$341K – 4083
2023
Q4 		$341K Sell
32,505
-1,627
-5% -$19.9K ﹤0.01% 3202
2023
Q3 		$448K Sell
34,132
-939
-3% -$12.3K ﹤0.01% 2966
2023
Q2 		$442K Sell
35,071
-1,095
-3% -$13.3K ﹤0.01% 3015
2023
Q1 		$472K Sell
36,166
-785
-2% -$12.7K ﹤0.01% 2947
2022
Q4 		$652K Buy
36,951
+12,698
+52% +$213K ﹤0.01% 2706
2022
Q3 		$369K Buy
24,253
+4,694
+24% +$75.9K ﹤0.01% 3049
2022
Q2 		$290K Sell
19,559
-3,447
-15% -$64.4K ﹤0.01% 3258
2022
Q1 		$518K Sell
23,006
-2,278
-9% -$46.1K ﹤0.01% 3058
2021
Q4 		$466K Buy
25,284
+950
+4% +$15.1K ﹤0.01% 3136
2021
Q3 		$325K Buy
24,334
+2,000
+9% +$32.3K ﹤0.01% 3357
2021
Q2 		$413K Buy
22,334
+5,778
+35% +$97.3K ﹤0.01% 3221
2021
Q1 		$249K Sell
16,556
-1,970
-11% -$31.5K ﹤0.01% 3483
2020
Q4 		$268K Sell
18,526
-16,485
-47% -$200K ﹤0.01% 3192
2020
Q3 		$285K Sell
35,011
-5,685
-14% -$46.5K ﹤0.01% 2989
2020
Q2 		$276K Sell
40,696
-2,065
-5% -$13.4K ﹤0.01% 2970
2020
Q1 		$301K Sell
42,761
-4,025
-9% -$32.7K ﹤0.01% 2770
2019
Q4 		$459K Sell
46,786
-8,345
-15% -$87.9K ﹤0.01% 2792
2019
Q3 		$605K Sell
55,131
-538
-1% -$5.52K ﹤0.01% 2523
2019
Q2 		$647K Buy
55,669
+6,083
+12% +$61.8K ﹤0.01% 2493
2019
Q1 		$473K Sell
49,586
-107,164
-68% -$1.18M ﹤0.01% 2692
2018
Q4 		$1.51M Sell
156,750
-18,751
-11% -$209K ﹤0.01% 1826
2018
Q3 		$2.5M Buy
175,501
+73,359
+72% +$997K ﹤0.01% 1681
2018
Q2 		$1.23M Buy
102,142
+44,472
+77% +$548K ﹤0.01% 2060
2018
Q1 		$712K Buy
+57,670
New +$819K ﹤0.01% 2345
2016
Q4 		– Sell
-15,149
Closed -$200K – 3380
2016
Q3 		$200K Buy
15,149
+2,750
+22% +$36.8K ﹤0.01% 2849
2016
Q2 		$157K Hold
12,399
– – ﹤0.01% 2721
2016
Q1 		$164K Sell
12,399
-10,182
-45% -$134K ﹤0.01% 2624
2015
Q4 		$347K Buy
22,581
+4,394
+24% +$63K ﹤0.01% 2144
2015
Q3 		$226K Buy
+18,187
New +$250K ﹤0.01% 2226
2014
Q4 		– Sell
-58,344
Closed -$783K – 2322
2014
Q3 		$783K Buy
58,344
+9,049
+18% +$137K ﹤0.01% 1630
2014
Q2 		$791K Buy
49,295
+5,374
+12% +$83.8K ﹤0.01% 1630
2014
Q1 		$792K Buy
43,921
+5,782
+15% +$100K 0.01% 1552
2013
Q4 		$590K Sell
38,139
-23,317
-38% -$344K ﹤0.01% 1598
2013
Q3 		$914K Buy
61,456
+20,737
+51% +$313K 0.01% 1305
2013
Q2 		$527K Buy
+40,719
New +$546K 0.01% 1500

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James & Associates's MDRX Position: Q1 2024 in Review

Raymond James & Associates sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 32,505 shares — an estimated $341K sold.

Raymond James & Associates first reported a position in MDRX in Q2 2013 and held it in 35 quarters. The position peaked at $2.5M in Q3 2018. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Raymond James & Associates reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Raymond James & Associates sold 32,505 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $341K.
  • Raymond James & Associates first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 35 quarters.
  • Raymond James & Associates's Veradigm Inc. Common Stock position peaked at $2.5M in Q3 2018.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.